Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD

One of the main problems in oncology is the development of drugs that cause the death of cancer cells without damaging normal cells. Another key problem to be solved is to suppress the drug resistance of cancer cells. The third important issue is to provide effective penetration of drug molecules to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadeev, Roman, Chekanov, Alexey, Solovieva, Marina, Bezborodova, Olga, Nemtsova, Elena, Dolgikh, Nadezda, Fadeeva, Irina, Senotov, Anatoly, Kobyakova, Margarita, Evstratova, Yana, Yakubovskaya, Raisa, Akatov, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387460/
https://www.ncbi.nlm.nih.gov/pubmed/30691192
http://dx.doi.org/10.3390/ijms20030525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387460/
https://www.ncbi.nlm.nih.gov/pubmed/30691192
http://dx.doi.org/10.3390/ijms20030525

Ejemplares similares